FORESEE 4 C C C C Trademark

Trademark Overview

On Friday, September 22, 2017, a trademark application was filed for FORESEE 4 C C C C with the United States Patent and Trademark Office. The USPTO has given the FORESEE 4 C C C C trademark a serial number of 87619228. The federal status of this trademark filing is REGISTERED as of Tuesday, September 21, 2021. This trademark is owned by Foresee Pharmaceuticals USA Inc.. The FORESEE 4 C C C C trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific study and research in the field of pharmaceuticals and pharmaceutical technologies and products
foresee 4 c c c c

General Information

Serial Number87619228
Word MarkFORESEE 4 C C C C
Filing DateFriday, September 22, 2017
Status700 - REGISTERED
Status DateTuesday, September 21, 2021
Registration Number6488864
Registration DateTuesday, September 21, 2021
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, July 6, 2021

Trademark Statements

Description of MarkThe mark consists of the wording "FORESEE 4 C C C C" in stylized form with the wording "FORESEE" appearing in dark blue font, the number "4" appearing in light blue, and the letters "C C C C" appearing in orange, yellow, brown and green. White is not claimed as a feature of the mark and appears merely as transparent background.
Pseudo MarkFORESEE 4CCCC; FORE SEE FOR COMFORT COMPLIANCE CONVENIENCE CURE; FORE SEE FOUR COMFORT COMPLIANCE CONVENIENCE CURE;
Indication of Colors claimedThe color(s) dark blue, light blue, orange, brown, yellow and green is/are claimed as a feature of the mark.
Goods and ServicesScientific study and research in the field of pharmaceuticals and pharmaceutical technologies and products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 28, 2017
Primary Code042
First Use Anywhere DateTuesday, January 1, 2013
First Use In Commerce DateTuesday, January 1, 2013

Trademark Owner History

Party NameForesee Pharmaceuticals USA Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNewark, DE 19711
Party NameForesee Pharmaceuticals USA Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewark, DE 19711
Party NameForesee Pharmaceuticals USA Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, DE 19711

Trademark Events

Event DateEvent Description
Tuesday, September 21, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, July 6, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 6, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 16, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 24, 2021ASSIGNED TO EXAMINER
Wednesday, April 14, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 14, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 14, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, February 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 12, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, March 21, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, March 21, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, March 21, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, March 21, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, March 21, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 12, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, August 29, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, February 28, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, February 22, 2019ASSIGNED TO LIE
Monday, July 30, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, July 30, 2018LETTER OF SUSPENSION E-MAILED
Monday, July 30, 2018SUSPENSION LETTER WRITTEN
Tuesday, July 3, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 2, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 2, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 25, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 25, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 3, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 3, 2018NON-FINAL ACTION E-MAILED
Wednesday, January 3, 2018NON-FINAL ACTION WRITTEN
Thursday, December 28, 2017ASSIGNED TO EXAMINER
Thursday, September 28, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 26, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

foresee pharmaceutical technologies products pharmaceuticals field study research scientific